AUB
CRL icon

Atlantic Union Bankshares’s Charles River Laboratories CRL Stock Holding History

Atlantic Union Bankshares’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Hold
200
– – ﹤0.01% 993
2025
Q4 		$39.9K Hold
200
– – ﹤0.01% 955
2025
Q3 		$31.3K Buy
+200
New +$31.8K ﹤0.01% 1024

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atlantic Union Bankshares's CRL Position: Q1 2026 in Review

Atlantic Union Bankshares held its Charles River Laboratories (CRL) position steady in Q1 2026 at 200 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Atlantic Union Bankshares first reported a position in CRL in Q3 2025 and has held it in 3 quarters since. The position peaked at $39.9K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Atlantic Union Bankshares held 200 shares of Charles River Laboratories worth $34.5K as of Q1 2026.
  • Atlantic Union Bankshares left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #993 holding.
  • Atlantic Union Bankshares first reported a position in Charles River Laboratories in Q3 2025 and has held it in 3 quarters since.
  • Atlantic Union Bankshares's Charles River Laboratories position peaked at $39.9K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.